Background -The use oflung sound mon-
. At the final stage of the challenge, wheeze was identified in 10 positive patients (48%) and in one negative patient (6%); in non-wheezers the inspiratory breath sound intensity decreased significantly from baseline in 11 CAC + patients (mean (SD) change -35 (24%)) but not in 16 CAC-patients (mean (SD) change 5 (24%)). In all non-wheezers a linear relationship was found between breath sound intensity and the squared inspiratory airflow (r=0.53-0.92) which became looser after the inhalation of carbachol.
Conclusion -When undertaking bronchial provocation testing the accurate identification of wheeze may prove useful in avoiding or shortening the test because of the presumed relationship between wheeze and airways hyperresponsiveness. Changes in breath sound intensity may also be useful, but further studies are required to define the threshold for significant changes in this index. (Thorax 1995; 50:955-961) Keywords: wheeze, breath sound intensity, lung sounds, carbachol airway challenge, airways responsiveness.
Non-specific bronchial responsiveness is a term used to describe the tendency of the airways to constrict upon exposure to non-allergic stimuli such as chemical mediators or physical stimuli. ' In the laboratory, bronchial responsiveness can be measured using inhalation provocation tests with either histamine or a cholinergic analogue such as methacholine.2 The bronchial response is usually assessed in terms of the provocative dose of the bronchoconstrictor agent leading to a 20% fall in the forced expiratory volume in one second (FEVy) .34 Obviously, the use of this technique is limited to subjects capable of performing technically acceptable forced expiratory manoeuvres.
It is a common clinical experience that lung sounds are generally abnormal in acute asthma. In mild disease expiratory wheezes may be heard over central airways. As the asthma becomes more severe, biphasic wheezes ofvarying pitch may be present all over the chest and, on occasion, they may be heard without the aid of a stethoscope. If asthma is severe wheezes may disappear and the chest may become silent, presumably because airflow is so markedly decreased that no energy is available for sound generation. These observations form the rationale for the many studies carried out over the past decade to examine the relationship between lung sounds and indices of airways obstruction in asthma or bronchial provocation testing. The (8 Hz) . Before Fourier analysis a Hanning window was applied to the data blocks to avoid aliasing. A wheeze was considered to be present when regular, sinusoidal-like oscillations were observed in the time expanded wave form analysis17 which corresponded to discrete narrow peak (or peaks) of power in the spectral analysis. Moreover, the following peak characteristics were required'9: (1) the peak had to be distinctly separate from its surrounding sound spectrum; (2) the peak amplitude had to be at least three times larger than the base it arose from; and (3) the width at half amplitude of the peak should not exceed three times the resolution of the measuring system (either 24 analysis was restricted to inspiration. In a preliminary study the variability (dispersion of successive measurements) and the short term reproducibility (difference at a certain time interval) of sound amplitude parameters were determined in five healthy volunteers from the laboratory by repeating the measurements 10 
Results
Of 38 patients, 21 (55 3%) had a positive CAC test (CAC +) and 17 had a negative test (CAC-). Of the 21 CAC+ patients seven had asthma, eight had rhinitis and/or nasal polyposis, three were investigated for cough, two for dyspnoea, and one had urticaria.
At baseline wheeze was identified in five patients. In two wheeze was inspiratory only, in one expiratory, and in two biphasic. The FEV, of the wheezers was not significantly different from that of the non-wheezers (mean (SD) -0-83 (0 98) standardised residuals versus -0-82 (0-97) respectively, p = 04). An example of inspiratory wheeze is shown in fig  1. At the end of the challenge these sounds were identified in 11 subjects (inspiratory in four, expiratory in four, and biphasic in the remaining three). Finally, in the post-bronchodilator step of the challenge wheezes were still present in six patients (inspiratory in three and expiratory in three).
Wheezes are identified at PD20 in 10 of the 21 CAC + patients (47 6%). In three the dose of carbachol at which the wheeze appeared (PDw) coincided with PD20; in two wheeze was identified respectively one and three steps before reaching PD20 so that PDw<PD20; in the remaining five wheeze was present already at baseline and persisted throughout the test even after the inhalation ofsalbutamol. Wheeze was also identified after all aerosols of carbachol in one of the 17 CAC -patients (5 9%) . Thus, at the final step of the challenge wheezes were 48% sensitive and 94% specific to detect a drop in FEVy by 20% or more.
In the 21 CAC+ patients the presence of wheeze correlated well with the severity of the spirometric response to carbachol: in wheezers (n = 10) the mean (SD) percentage fall in FEV, At PD20, the inspiratory breath sound intensity decreased noticeably from baseline in CAC + non-wheezers but not in CAC-nonwheezers; the mean (SD) individual variation in breath sound intensity expressed as a percentage of the initial value for the two subgroups was -35 (24)% and 5 (24)%, respectively (p<0001).
The absolute values ofbreath sound intensity and other acoustic and ventilatory variables observed at each step of the challenge are shown separately for the two subgroups of non-wheezers in table 3. The main differences between these two subgroups can be summarised as follows: (a) in CAC + patients inspiratory time increased significantly after the inhalation of carbachol but did not return towards baseline after the inhalation of salbutamol; (b) in CAC + patients both breath sound intensity and inspiratory flow (VT/Ti) decreased significantly after the inhalation of carbachol and increased back towards baseline values after the inhalation of salbutamol; (c) in both subgroups a positive linear relationship was found between breath sound intensity and the corresponding squared inspiratory airflow with correlation coefficients (r) at baseline ranging from 0-53 to 0-92, and (d) in CAC+ patients both the slope and the coefficient of correlation of the breath sound intensity/ squared flow curve decreased significantly at PD20.
Discussion
This study identified wheeze in 48% of those subjects with a positive carbachol challenge test and in the remainder the breath sound intensity fell markedly, whereas in those with a negative challenge test only one subject (6%) wheezed and in the remainder breath sound intensity was essentially unchanged. These results suggest a possible role for lung sound monitoring in the context of tests for bronchial hyperresponsiveness.
Wheeze is an adventitious musical sound usually associated with obstructive disorders of the airways. The results of this study confirm our previous observations" and those of others"94 that this sign is a poorly sensitive but highly specific detector of airways obstruction. This finding is in keeping with the mechanism of wheeze generation as proposed by Grotberg and Davis2' and by Gavriely and coworkers. [22] [23] [24] [25] According to these authors, wheeze would result from the coupled oscillation ofthe airway gas and the airway wall in partially collapsed central airways which occurs when airflow velocity increases above a critical threshold, and the pleural pressure reaches a critical value greater than that required for airways limitation. Since wheeze generation requires airways limitation at a local level, this sign can, but does not necessarily have to be, related to FEVI, an index expressing overall airways limitation. Conversely, overall airways obstruction may coexist with an absence of wheeze.
A clinically useful approach is to analyse the appearance of wheeze during airway inhalation tests in the light of its presumed relationship with airways hyperresponsiveness. Holgate and coworkers26 have stressed that, from a symptomatic point of view, airways hyperresponsiveness is related to bronchial irritability (which presents as attacks of wheezing, chest tightness, or shortness of breath upon exposure to various stimuli27), and that "bronchial hyperresponsiveness and irritability are intimately associated with paroxysms of bronchospasm that characterise asthma and comprise a major part of its clinical definition".28 It therefore seems reasonable to consider that wheeze triggered by non-specific stimuli is in itself a manifestation of airways hyperresponsiveness, a concept that seems to be shared by others.' 13 29 The adoption of the above concept in pulmonary function testing would have had several practical consequences for our patients. Firstly, smaller doses of carbachol would have been The changes in breath sound intensity reLged from ported herein are at variance with two previous Ltient who reports. In one, Tinkelman and colleagues37 carbachol claimed breath sound intensity to significantly FEV, fell increase at PD20 during methacholine chalLenge. In-lenge testing in children between two and six iker com-years old. However, in that study the two phases less, and of the respiratory cycle were not examined ust in the separately, neither were wheezers separated ted char-from non-wheezers. Thus the hypothesis that Jot worse the low energy breath sound was "conisiderably taminated" by the high energy wheezes cannot r, at least be ruled out. In the second study, aimed prim-)efore the arily at examining the changes in frequency ave been spectra ofbreath sounds during histamine chalAlthough lenge testing, Malmberg and coworkers'2 measthey had ured breath sound intensity simultaneously at dence of the trachea and over the chest in 12 adult l= 1). In asthmatic subjects and six healthy controls. that they In both groups the average inspiratory breath only, the sound intensity over the chest did not In conclusion, this study showed that wheeze identification before and after the inhalation of a cholinergic agent is clinically useful provided the concept is accepted that pharmacologically triggered wheeze is as legitimate a manifestation of airways hyperresponsiveness as is a fall in FEV1. In practice this should prompt the discontinuation of the challenge test or, at least, the lowering of the next dose of the provocative drug. In turn, the presence of wheeze before the challenge can, in the appropriate context, be considered as enough evidence of airway hyperresponsiveness to exempt the patient from the test; if deemed necessary the latter could be carried out employing a low dose protocol as for asthmatics, regardless of the baseline FEV1. Finally, by extension, the monitoring of inspiratory breath sound intensity seems to be potentially useful; however, as this index has a quantitative dimension further research is necessary to define the range of normal variation.
